Q2 2010

Filed Nov 19, 2010 · 10-Q · 50 days after period end · 0001185185-10-001365

Q2 2010 · 10-Q

Revenue

$1.68M

no prior Q2 2009 on file

Net Income

-$856.26K

no prior Q2 2009 on file

EPS Diluted

-$0.06

no prior Q2 2009 on file

Operating Income-$795,810—

Operating Cash Flow

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 19, 2010 · 50 d after period end

IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR